4//SEC Filing
Chapman Marcus 4
Accession 0000899243-21-005254
CIK 0001609809other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 6:55 PM ET
Size
8.0 KB
Accession
0000899243-21-005254
Insider Transaction Report
Form 4
Chapman Marcus
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2021-02-04+24,000→ 24,000 totalExercise: $26.34Exp: 2031-02-03→ Common Stock (24,000 underlying) - Award
Restricted Stock Units
2021-02-04+12,000→ 12,000 total→ Common Stock (12,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units will vest and settle as to 25% of the restricted stock units on March 15, 2022. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter.
- [F3]The option will vest as to 25% of the shares on February 4, 2022. The remainder of the shares will vest in 12 equal quarterly installments thereafter.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001770404
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 6:55 PM ET
- Size
- 8.0 KB